Cat.No. | Name | Information |
---|---|---|
M1973 | Ostarine (GTx-024) | Ostarine (GTx-024 and MK-2866) is an investigational selective androgen receptor modulator (SARM) with Ki of 3.8 nM. |
M6105 | Testosterone | Testosterone is an androgen, which binds the androgen receptor. |
M5565 | Dexmedetomidine HCl | Dexmedetomidine Hydrochloride is an agonist of adrenergic alpha-2 receptor, which is used in veterinary medicine for its analgesic and sedative properties. |
M5805 | Nandrolone | Nandrolone is a synthetic, anabolic steroid analog of testosterone. |
M3502 | Testosterone cypionate | Testosterone cypionate is the oil-soluble 17 (beta)-cyclopentylpropionate ester of the androgenic hormone testosterone. |
M8128 | R1881 | R1881 (Metribolone) is an orally active, non-aromatisable androgen and anabolic steroid. |
M1839 | MDV3100 | MDV3100 is an orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. |
M5764 | Medroxyprogesterone acetate | Medroxyprogesterone acetate (MPA) is a synthetic progestin and act as a potent progesterone receptor agonist, used to treat abnormal menstruation or irregular vaginal bleeding. |
M50379 | Adrenocorticotropic hormone | Adrenocorticotropic hormone (ACTH) is a polypeptide tropic hormone produced by the anterior pituitary gland. |
M50378 | LH-RH II (chicken) | LH-RH II (chicken) is one of the two forms of luteinizing hormone-releasing hormone (LHRH) the hypothalamus of the domestic hen, which are structural variants of mammalian LHRH. |
M43901 | TAS3681 | TAS3681 is an androgen receptor (AR) inhibitor that may be used in studies related to prostate cancer. |
M43900 | ONC1-13B | ONC1-13B is an androgen receptor (AR) inhibitor that can be used in studies related to denervation-resistant prostate cancer (CRPC). |
M43896 | Zanoterone | Zanoterone is an androgen receptor (AR) inhibitor that may be used in studies related to prostate cancer. |
M43589 | Androgen receptor degrader-3 | Androgen receptor degrader-3 is an androgen receptor degrader. |
M43588 | YXG-158 | YXG-158 is an orally active AR degrader and CYP17A1 inhibitor. |
M43587 | Androgen receptor degrader-2 | Androgen receptor degrader-2 is a potent androgen receptor degrader. |
M43586 | Androgen receptor degrader-1 | Androgen receptor degrader-1 is a potent androgen receptor degrader. |
M43585 | WCA-814 | WCA-814 is an androgen receptor (AR) antagonist-Hsp90 inhibitor conjugate. |
M43584 | Androgen receptor antagonist 8 | Androgen receptor antagonist 8 is an androgen receptor antagonist. |
M43583 | JNJ-26146900 | JNJ-26146900 is a potent and orally active androgen receptor antagonist with a Ki value of 400nM for rat AR. |
M43582 | JJH260 | JJH260 is AIG1 inhibitor, and inhibit the fluorophosphonate reactivity and fatty acid esters of hydroxy fatty acid (FAHFA) hydrolysis activity of AIG1in HEK293T cells. |
M40985 | LPCN 1144 | LPCN 1144 is an androgen receptor (AR) agonist that may be used in studies related to non-alcoholic steatohepatitis (NASH). |
M39856 | Linuron | Linuron is a photosystem II inhibitor. Linuron is also a competitive androgen receptor (AR) antagonist with a Ki of 100 μM. Linuron shows reproductive toxicity in animals that acts as an endocrine disruptor. |
M39855 | Galloylalbiflorin | Galloylalbiflorin (6′-O-Galloylalbiflorin) is an androgen receptor (AR) antagonist (IC50=53.3 μM) and can be found in the roots of Paeonia lactiflora. Galloylalbiflorin shows anti-androgens activity. |
M30769 | AC-262536 | AC-262536 is a selective and non-steroidal androgen receptor modulators (SARMs) with beneficial anabolic effects. AC-262536 exhibits potent agonist activity at the androgen receptor, with an affinity in the low nanomolar range (1-10 nM). |
M30724 | AH3960 | AH3960 (compound 16c) is an antagonist of androgen receptor. AH3960 binds wild as well as T877 mutant type androgen receptors. AH3960 selectively inhibits T877 with an IC50 value of 0.82 μM. AH3960 also serves as an agonist of parathyroid hormone receptor-1 (PTHR1). |
M30623 | MK-4541 | MK-4541 is an orally active and selective androgen receptor (AR) modulator. MK-4541 acts as an antagonist to inhibit 5α-reductase. MK-4541 inhibits proliferation and induces apoptosis in AR positive prostate cancer cells. MK-4541 significantly inhibited the growth of R3327-G prostate tumors in xenograft mouse model. |
M29958 | AR antagonist 3 | AR antagonist 3 is a potent and selective androgen receptor (AR) antagonist with an IC50 of 0.47 µM. AR antagonist 3 exhibits a dose-dependent decrease of the FRET signal (IC50= 18.05 μM). AR antagonist 3 shows effective inhibition on tumor growth when administered intratumorally. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.